Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis
Diabetic nephropathy (DN) is a common diabetic complication. Long noncoding RNAs (lncRNAs) have been identified as essential regulators in DN progression. This study is devoted to the research of lncRNA-myocardial infarction-associated transcript (MIAT) in DN.
Main Authors: | Dong Qianlan, Wang Qiong, Yan Xiaohui, Wang Xiaoming, Li Zhenjiang, Zhang Linping |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-09-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2021-0328 |
Similar Items
-
Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality
by: Wenzheng Guo, et al.
Published: (2019-06-01) -
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
by: Alexander Greenhough, et al.
Published: (2018-11-01) -
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
by: Lidia Moyano‐Galceran, et al.
Published: (2020-04-01) -
Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway
by: Min Sha, et al.
Published: (2018-03-01) -
The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer
by: Bin Liu, et al.
Published: (2018-06-01)